Jenoptik AG (ETR:JEN) has been given an average recommendation of “Hold” by the nine analysts that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is €31.81 ($36.99).
A number of equities analysts have recently weighed in on the stock. DZ Bank reissued a “neutral” rating on shares of Jenoptik in a research report on Tuesday, August 14th. Hauck & Aufhaeuser set a €42.00 ($48.84) price target on shares of Jenoptik and gave the stock a “buy” rating in a research report on Monday, August 13th. Independent Research set a €28.00 ($32.56) price target on shares of Jenoptik and gave the stock a “sell” rating in a research report on Friday, August 10th. Deutsche Bank set a €31.00 ($36.05) price target on shares of Jenoptik and gave the stock a “neutral” rating in a research report on Friday, August 10th. Finally, Warburg Research set a €33.00 ($38.37) price target on shares of Jenoptik and gave the stock a “neutral” rating in a research report on Thursday, August 9th.
Shares of ETR JEN traded down €0.30 ($0.35) during midday trading on Monday, reaching €27.86 ($32.40). 77,132 shares of the stock were exchanged, compared to its average volume of 191,081. Jenoptik has a 12 month low of €20.68 ($24.05) and a 12 month high of €34.82 ($40.49).
Jenoptik Company Profile
Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.
See Also: Put Option
Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.